Haemonetics
- Market cap
- 4.63B
- P/E (TTM)i
- 49.14
- P/Bi
- 5.53
- EPSi
- 2.05
- Div yieldi
- 0.00%
- 52W posi
- 86%
Anonymous reader poll. Unscientific, not investment advice.
About Haemonetics
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
- Founded
- 1971
- CEO
- Mr. Christopher A. Simon
- Employees
- 3,009
- Headquarters
- Boston, Massachusetts, United States of America
- Fiscal year end
- 04-03
- Website
- haemonetics.com
Company profile
- Exchange
- US
- Symbol
- HAE
- Market-cap rank
- #2165
- Listing date
- 1970-01-01
- Market cap
- 4.63B
- Float cap
- 4.57B
- Shares out
- 45.50M
- Float shares
- 44.89M
Sectors & themes
Quote time 2026-10-08 09:20:20 · For reference only, not investment advice and not tailored to your situation.